statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ascendis Pharma A/S (NASDAQ:ASND) Given New $167.00 Price Target at JPMorgan Chase & Co.

Ascendis Pharma A/S (NASDAQ:ASND - Free Report) had its target price boosted by JPMorgan Chase & Co. from $165.00 to $167.00 in a research note issued to investors on Tuesday morning, Benzinga...

Ascendis Pharma A/S (NASDAQ:ASND) Given "Overweight" Rating at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in a report published on Monday morning, Benzinga reports. Cantor Fitzgerald...

Ascendis Pharma A/S (ASND, $151.98) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

This is a Bullish indicator signaling ASND's price could rise from here. Traders may explore going long the stock or buying call options...

Ascendis Pharma A/S (ASND, $151.98) Stochastic Oscillator left the overbought zone on April 01, 2024

This is a signal that ASND's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Values First Advisors Inc. Lowers Position in Ascendis Pharma A/S (NASDAQ:ASND)

Values First Advisors Inc. reduced its stake in Ascendis Pharma A/S (NASDAQ:ASND  Free Report) by 23.4% in the fourth quarter, according to its most recent filing with the Securities and...

Ascendis Pharma A/S (ASND, $148.44) Stochastic Oscillator left the oversold zone on March 27, 2024

This is a signal that ASND's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

1,616 Shares in Ascendis Pharma A/S (NASDAQ:ASND) Purchased by Legato Capital Management LLC

Legato Capital Management LLC purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND  Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities...

Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Ascendis Pharma A/S (NASDAQ:ASND  Get Free Report) have been assigned an average rating of Moderate Buy from the ten analysts that are covering the firm, MarketBeat...

Ascendis Pharma A/S (ASND, $145.37) Stochastic Oscillator left the oversold zone on March 19, 2024

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Volume	175,736.00
52-Wk High	$161.00
52-Wk Low	$85.29

ASND Ascendis Pharma

About

Feed

News

Sentiment

Earnings

Fundamentals